BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1676898)

  • 1. Correlation of spontaneous suppressor cell activity with progression of human immunodeficiency virus infection.
    Mullin G; Mayer L
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):387-92. PubMed ID: 1676898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
    McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
    Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous suppressor cell activity in patients with the acquired immune deficiency syndrome and associated conditions.
    Katner HP; deShazo RD; Pankey GA; Andes WA; Daul CB; Cortez L; Dalovisio J; Bozelka B
    J Allergy Clin Immunol; 1987 Feb; 79(2):364-70. PubMed ID: 2950158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA-anti-Fab autoantibodies and disease progression in AIDS.
    Süsal C; Daniel V; Doerr C; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 1993 Apr; 36(1):27-30. PubMed ID: 8102124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The possibilities of using immunological indices as criteria for determining the stage of HIV infection and the disease prognosis].
    Chernousov AD; Eremina OF; Simonova AV; Kulakov VV; Borisova AM; Pinegin BV
    Vestn Ross Akad Med Nauk; 1992; (11-12):13-5. PubMed ID: 1284213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T4 lymphocytes (helper cells) and T8 lymphocytes (cytotoxic and suppressor cells) in patients with asymptomatic and symptomatic HIV infection].
    Radkowski M; Laskus T; Kopicz-Kamińska E; Mian M; Babiuch L; Slusarczyk J
    Pol Arch Med Wewn; 1991 Oct; 86(4):239-46. PubMed ID: 1687608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of IL-2, IL-1 alpha, TNF-alpha, and soluble receptor of IL-2 in HIV-1-infected patients.
    Scott-Algara D; Vuillier F; Marasescu M; de Saint Martin J; Dighiero G
    AIDS Res Hum Retroviruses; 1991 Apr; 7(4):381-6. PubMed ID: 1676897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
    Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; González-Lahoz J
    N Engl J Med; 1993 Jul; 329(5):297-303. PubMed ID: 8100611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.
    Natoli C; Dianzani F; Mazzotta F; Balocchini E; Pierotti P; Antonelli G; Iacobelli S
    J Acquir Immune Defic Syndr (1988); 1993 Apr; 6(4):370-5. PubMed ID: 8095982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, randomized, placebo-controlled study of ditiocarb (Imuthiol) in human immunodeficiency virus-infected asymptomatic and minimally symptomatic patients. The HIV87 Study Group.
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):83-9. PubMed ID: 8094001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Manifestation of AIDS in HIV infected homosexual males with lymphadenopathy syndrome].
    Harrer T; Messing K; Bienzle U; Meyer E; Giedl J; Kalden JR
    Klin Wochenschr; 1989 Sep; 67(18):936-9. PubMed ID: 2571742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex.
    Goldsmith JM; Kalish SB; Ostrow DG; Britz J; Chmiel JS; Wallemark CB; Phair JP
    Sex Transm Dis; 1987; 14(1):44-7. PubMed ID: 2951878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed hypersensitivity skin tests in prognosis of human immunodeficiency virus infection.
    Zeballos RS; Cavalcante N; Freire CA; Hernandez HJ; Longo IM; Peixinho ZF; Moura NC; Mendes NF
    J Clin Lab Anal; 1992; 6(3):119-22. PubMed ID: 1354723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients.
    Ray K; Gupta SM; Bala M; Muralidhar S; Kumar J
    Indian J Med Res; 2006 Sep; 124(3):319-30. PubMed ID: 17085836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients.
    Hutterer J; Fuchs D; Eder G; Hausen A; Knapp W; Köller U; Reibnegger G; Werner ER; Wachter H; Stingl G
    Wien Klin Wochenschr; 1987 Aug; 99(15):531-5. PubMed ID: 2958970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity.
    Salazar-Gonzalez JF; Moody DJ; Giorgi JV; Martinez-Maza O; Mitsuyasu RT; Fahey JL
    J Immunol; 1985 Sep; 135(3):1778-85. PubMed ID: 2991373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation study of HIV/AIDS abnormal immune activation and disease progression].
    Wang J; Wu XF; Li Y; Zeng Y
    Zhongguo Zhong Yao Za Zhi; 2013 Aug; 38(15):2429-33. PubMed ID: 24228529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.
    Gruters RA; Terpstra FG; De Jong R; Van Noesel CJ; Van Lier RA; Miedema F
    Eur J Immunol; 1990 May; 20(5):1039-44. PubMed ID: 2162775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.